Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have had, or are planning to have, a medical procedure using one or more specific Abbott medical devices covered by this registry
- People who are willing and able to attend follow-up appointments as outlined in the study plan, or who have already completed them
- People who are able to provide written consent before any study-related data is collected, or those enrolled under an approved consent waiver
Who may not be able to join:
- People who have had active symptoms of COVID-19, or a positive COVID-19 test result, or symptoms or a positive test for another rapidly spreading new infectious disease, within the 2 months before their procedure date
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chananit Hutson, PhD, Abbott Medical Devices
Phone: +1 714-926-8292
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Coronary Stents - Number of participants with composite of all-cause death, MI or target lesion revascularization (TLR); Coronary Stents - Number of participants with composite of all-cause death, MI or target lesion revascularization (TLR); Coronary Stents - Number of participants with composite of all-cause death, MI or target lesion revascularization (TLR); Peripheral Stents - Number of participants with composite of all-cause death, amputation, and TLR; Peripheral Stents - Number of participants with composite of all-cause death, amputation, and TLR; Peripheral Stents - Number of participa...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.